Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Moemoney42on Feb 28, 2021 11:12pm
199 Views
Post# 32683250

RE:THRM Compared to Competition

RE:THRM Compared to CompetitionNot sure where you're getting this data from as it is very misleading..!!!!
Global care capital doesn't even make a covid test..!!

Sona's test isn't $100 each..!!
As far as that goes I don't believe any of the companies you've quoted have that price point for their test..!
Bunch of BS if you ask me..!!
Watchman21 wrote:
Basic math on why I think THRM will be the leader in this Covid19 testing space...not only because their results from frozen saliva 86%-100%, but also their production capabilities for an off-the-shelf test-at-home solutions that's saliva based versus the Point-of-Care nasal swab tests.  


Company Symbol Shares Out Share Value Market Cap Covid19 Test Type Test Type Daily Production/ Test Potential Weekly Production/ Test Potential Monthly Production/ Test Potential Production & Testing Scalability Test Kit Price Monthly Value
Therma Bright THRM    199,020,000.00   $         0.35   $    69,657,000  Saliva At-Home Test                  33,333                      233,331                     1,000,000   Large Volume Growth, as its simply producing tests. General Consumers to implement   $       30.00   $   30,000,000.00 
Empower Clinic CBDT    293,390,000.00   $         1.19   $  349,134,100  Nasal Point-of-Care Test / Clinic                    1,000                          7,000                          30,000   Small volume growth, requires test administrator   $     100.00   $     3,000,000.00 
SONA SONA    202,870,000.00   $         0.23   $    46,660,100  Nasal (& Saliva?) Point-of-Care Test / Clinic                    1,000                          7,000                        210,000   Small volume growth, requires test administrator   $     100.00   $   21,000,000.00 
Sparta Capital SAY      61,210,000.00   $         1.90   $  116,299,000  Nasal   Point-of-Care Test / Clinic                    1,000                          7,000                        210,000   Small volume growth, requires test administrator   $     100.00   $   21,000,000.00 
Global Care Capital HLTH    210,110,000.00   $         0.18   $    36,769,250  Nasal Point-of-Care Test / Clinic                    1,000                          7,000                        210,000   Small volume growth, requires test administrator   $     100.00   $   21,000,000.00 
Datametrex DM    276,870,000.00   $         0.28   $    77,523,600  Nasal Point-of-Care Test / Clinic                    1,714                        12,000                          52,000   Small volume growth, requires test administrator   $     100.00   $     5,200,000.00 
                         
NOTE 1: SONA, SPARTA & Global Care have not sahred daily test production or test implementation in any NR, so each probably has the same daily test production/implementation capabilitiy as Empower Clinics of 1000+ per day.  
NOTE 2: Covid 19 TEST COSTS: are estimated at $150 per person per test, so the price per test kit from each manufacturer is no greater than $100.          
                         



<< Previous
Bullboard Posts
Next >>